Last Chance for Animals
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 24, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, with nine offices in eight cities around the country and eighty attorneys, reminds investors in Cognizant Technology...
Bragar Eagel & Squire
NEW YORK, May 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against AZZ Inc. (NYSE: AZZ) on behalf of AZZ stockholders. Our investigation concerns...
Gainey McKenna & Egleston
NEW YORK, May 24, 2019 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against PriceSmart, Inc. (“PriceSmart” or the “Company”) (Nasdaq: PSMT)...
Last Chance for Animals
LOS ANGELES, May 24, 2019 (GLOBE NEWSWIRE) -- Last Chance for Animals (LCA) is proud to receive nine Telly Awards in the Gold, Silver, and Bronze categories. One of the world’s most prominent and...
Block & Leviton LLP
BOSTON, May 24, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a national securities litigation firm, is investigating whether Mammoth Energy Services, Inc. (NASDAQ: TUSK) and...
Anconia Resources Corp.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 24, 2019 (GLOBE NEWSWIRE) -- Anconia Resources Corp. (TSXV: ARA) (“Anconia” or the...
Boaz Pharmaceuticals Inc.
CALGARY, Alberta, May 24, 2019 (GLOBE NEWSWIRE) -- BOAZ Pharmaceuticals Inc. is now licensed to sell handcrafted cannabis in Canada to medical clients and the recreational market through its online...
The Royal Canadian Legion
OTTAWA, May 24, 2019 (GLOBE NEWSWIRE) -- The Royal Canadian Legion’s National Headquarters is pleased to introduce its new National Executive Director, Steven Clark. Clark officially began his role...
Empire Industries
WINNIPEG, Manitoba, May 24, 2019 (GLOBE NEWSWIRE) -- Empire Industries Ltd. (TSX-V: “EIL”, “Empire” or the “Company”) is pleased to announce that it has closed the second tranche of the non-brokered...
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 24, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated...
